ENDO INTERNATIONAL PLC overview

Endo, Inc. Completes Acquisition of Endo International plc's Assets PR Newswire MALVERN, Pa., April 23, 2024 Newly Formed Company Poised for Sustained Growth With a Strengthened Balance Sheet, Resolved Litigation Overhang, Diversified Portfolio of Medicines and a Deep New Product Pipeline MALVERN, Pa. , April 23, 2024 /PRNewswire/ -- Endo, Inc. ("Endo" or the "Company"), a newly formed entity, today announced that it has successfully completed the previously announced acquisition of...

Par Pharmaceutical Issues Voluntary Nationwide Recall of Seven Lots of Treprostinil Injection Due to Potential for Silicone Particulates in the Product Solution PR Newswire DUBLIN, April 22, 2024 DUBLIN , April 22, 2024 /PRNewswire/ -- Endo International plc announced today that one of its operating companies, Par Pharmaceutical, Inc. (Par), is expanding its voluntary recall to include seven lots of Treprostinil Injection 20mg/20mL (1mg/mL) to the consumer level. The product is being recalled...

Endo, Inc. Announces Pricing of $1.5 billion of Senior Secured Term Loan as Part of Endo's $2.5 billion Exit Financing PR Newswire MALVERN, Pa., April 12, 2024 MALVERN, Pa. , April 12, 2024 /PRNewswire/ -- Endo, Inc. ("Endo"), a newly formed entity, today announced that its wholly-owned subsidiary Endo Finance Holdings, Inc. (the "Borrower") priced its $1,500.0 million senior secured seven-year term loan (the "Term Loan"). To optimize the exit financing transactions, the Borrower has (i)...

Endo, Inc. Announces Pricing of $1.0 billion of Senior Secured Notes PR Newswire MALVERN, Pa., April 12, 2024 Offering Part of Endo's $2.5 billion Exit Financing MALVERN, Pa. , April 12, 2024 /PRNewswire/ -- Endo, Inc. ("Endo"), a newly formed entity, today announced that its wholly-owned subsidiary Endo Finance Holdings, Inc. (the "Issuer") priced $1,000.0 million aggregate principal amount of its 8.500% senior secured notes due 2031 (the "Notes"). To optimize the exit financing transactions,...

Endo, Inc. Announces Proposed Private Offering of Senior Secured Notes PR Newswire MALVERN, Pa., April 8, 2024 Part of Endo's $2.5 Billion Exit Financing MALVERN, Pa. , April 8, 2024 /PRNewswire/ -- Endo, Inc. ("Endo"), a newly formed entity, today announced that its wholly-owned subsidiary Endo Finance Holdings, Inc. (the "Issuer") intends to offer senior secured notes (the "Notes"), subject to market and customary conditions. The Notes will be senior secured obligations of the Issuer and will...

Endo, Inc. Announces Proposed New Senior Secured Credit Facilities PR Newswire MALVERN, Pa., April 1, 2024 MALVERN, Pa. , April 1, 2024 /PRNewswire/ -- Endo, Inc. ("Endo"), a newly formed entity, today announced that its wholly-owned subsidiary Endo Finance Holdings, Inc. (the "Borrower") intends to enter into new senior secured credit facilities consisting of: (i) a $400.0 million five-year super-priority revolving credit facility (the "New Revolving Facility"); and (ii) a $1,250.0 million...

Endo Launches Ibuprofen-Famotidine Tablets, Generic Version of DUEXIS® PR Newswire DUBLIN, March 26, 2024 DUBLIN , March 26, 2024 /PRNewswire/ -- Endo International plc (OTC: ENDPQ) announced today that one of its operating companies, Par Pharmaceutical, Inc., launched ibuprofen-famotidine 800 mg/26.6 mg tablets, a generic version of Amgen's (formerly Horizon Therapeutics) DUEXIS ® . "We're proud to provide affordable choices to healthcare providers and their appropriate patients while...

Endo Announces Confirmation of Plan of Reorganization PR Newswire DUBLIN, March 19, 2024 Anticipates Completing Financial Restructuring as Early as Late April 2024 DUBLIN , March 19, 2024 /PRNewswire/ -- Endo International plc (OTC: ENDPQ) ("Endo" or the "Company") today announced that the United States Bankruptcy Court for the Southern District of New York has confirmed its Chapter 11 plan of reorganization (the "Plan"), clearing the path for the Company to successfully complete its financial...